V

VERA

Vera Therapeutics, Inc.
HealthcareBiotechnology|NASDAQ Global Market|US

Price

$40.86

Market Cap

$2.92B

Beta

1.17

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)-61.81%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio
FCF Yield-8.29%
Debt / Equity0.13
Interest Coverage-28.0x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for VERA.

VERA — Vera Therapeutics, Inc. Stock Analysis | Tessera Alpha